Home Page - Abzena

Abzena provides technologies and complementary services across Biology, Chemistry and Manufacturing.





About Us Contact Us

Abzena secures ADC manufacturing services contract

Following the initial chemistry development, Abzena subsequently developed a cell line that will now be used to produce the antibody at its GMP manufacturing facility. Abzena will also conduct GMP production of the ADC payload reagent and the conjugation process to create the ADC for initial clinical study.

Read More

New target for the treatment of Cardiovascular Fibrosis developed by Enleofen Bio, with support from Abzena, featured in ‘Nature’ article

Abzena will also support Enleofen Bio through the development of alternative strategies to block IL11 signalling. Abzena’s wide range of protein engineering technologies will help to translate findings from successful proof-of-concept studies in preclinical models of disease to the clinic.

Read More

Abzena and Telix sign licence agreement for Abzena’s Prostate-Specific Membrane Antigen Antibodies

Under the terms of the Agreement, Abzena has granted Telix an exclusive worldwide, royalty bearing, sub-licensable licence to its prostate-specific membrane antigen (‘PSMA’) antibodies in the field of radio-immunoconjugation. The PSMA antibodies were created using Abzena’s Composite Human Antibody™ technology.

Read More

Technologies and Solutions

Abzena provides proprietary technologies and complementary solutions to organisations involved in the development of biopharmaceutical products.

Latest News and Events

Abzena presents its latest research and exhibits at events all over the world.
Find out where we are next and our latest news below.

Load More

Resources and Downloads

Find our latest videos, brochures and fact sheets in our resources section.

Download our Brochure

Technology & Solutions Brochure

Download File

Modulation of drug-linker design to enhance in vivo potency of homogeneous antibody-drug conjugates

Antibody-drug conjugates (ADCs) are a promising class of anticancer agents which have undergone substantial development…

Read More

Manufacturing & Cell Line Development at Abzena

Abzena has extensive experience in cGMP and non-GMP production for recombinant proteins, antibodies and conjugates…

View All Resources